Preclinical drug development hinges on rigorous, regulatory-aligned safety and toxicology evaluation, serving as the critical gateway to successful Investigational New Drug (IND) submissions and safe clinical trial
Introduction In the field of life sciences and medical research, 3D cell culture technology is quietly transforming our understanding of the cellular world. Unlike conventional
Introduction SSTI Skin and soft tissue infections (SSTI) represent one of the most common spectrums of infectious diseases in clinical practice, with a wide range of
Introduction CRPV Human papillomavirus (HPV) infection represents a major global public health challenge with high prevalence. Persistent infection with high-risk HPV can induce malignant lesions
1Introduction In August 2026, a milestone breakthrough was achieved in hepatitis B treatment. Japan’s Ministry of Health, Labour and Welfare approved the launch of bepirovirsen
01 Background Allergic Rhinitis Allergic Rhinitis (AR) is an IgE‑mediated chronic inflammatory disease of the nasal mucosa, mainly manifested by symptoms such as nasal pruritus, sneezing, rhinorrhea and
Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china
